Source:http://linkedlifedata.com/resource/pubmed/id/19415665
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2009-8-17
|
pubmed:abstractText |
Our aim was to determine whether a Vaccinium myrtillus (bilberry) anthocyanoside (VMA) and/or its main anthocyanidin constituents (cyanidin, delphinidin, and malvidin) can protect retinal ganglion cells (RGCs) against retinal damage in vitro and in vivo. In RGC cultures (RGC-5, a rat ganglion cell-line transformed using E1A virus) in vitro, cell damage and radical activation were induced by 3-(4-morpholinyl) sydnonimine hydrochloride (SIN-1, a peroxynitrite donor). Cell viability was measured using a water-soluble tetrazolium salt assay. Intracellular radical activation within RGC-5 cells was evaluated using 5-(and-6)-chloromethyl-2,7-dichlorodihydrofluorescein diacetate acetyl ester (CM-H(2)DCFDA). Lipid peroxidation was assessed using the supernatant fraction of mouse forebrain homogenates. In mice in vivo, we evaluated the effects of VMA on N-methyl-D-aspartic acid (NMDA)-induced retinal damage using hematoxylin-eosin and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) stainings. VMA and all three anthocyanidins (i) significantly inhibited SIN-1-induced neurotoxicity and radical activation in RGC-5, (ii) concentration-dependently inhibited lipid peroxidation in mouse forebrain homogenates. Intravitreously injected VMA significantly inhibited the NMDA-induced morphological retinal damage and increase in TUNEL-positive cells in the ganglion cell layer. Thus, VMA and its anthocyanidins have neuroprotective effects (exerted at least in part via an anti-oxidation mechanism) in these in vitro and in vivo models of retinal diseases.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-morpholino-sydnonimine,
http://linkedlifedata.com/resource/pubmed/chemical/Anthocyanins,
http://linkedlifedata.com/resource/pubmed/chemical/Molsidomine,
http://linkedlifedata.com/resource/pubmed/chemical/N-Methylaspartate,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1613-4133
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
869-77
|
pubmed:meshHeading |
pubmed-meshheading:19415665-Animals,
pubmed-meshheading:19415665-Anthocyanins,
pubmed-meshheading:19415665-Apoptosis,
pubmed-meshheading:19415665-Cells, Cultured,
pubmed-meshheading:19415665-Chromatography, High Pressure Liquid,
pubmed-meshheading:19415665-Lipid Peroxidation,
pubmed-meshheading:19415665-Male,
pubmed-meshheading:19415665-Mice,
pubmed-meshheading:19415665-Molsidomine,
pubmed-meshheading:19415665-N-Methylaspartate,
pubmed-meshheading:19415665-Neuroprotective Agents,
pubmed-meshheading:19415665-Prosencephalon,
pubmed-meshheading:19415665-Retinal Ganglion Cells,
pubmed-meshheading:19415665-Vaccinium myrtillus
|
pubmed:year |
2009
|
pubmed:articleTitle |
Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage in vitro and in vivo.
|
pubmed:affiliation |
Department of Biofunctional Evaluation, Molecular Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
|
pubmed:publicationType |
Journal Article
|